Impact of type 2 diabetes on adenoma detection in screening colonoscopies performed in disparate populations

doi:10.12998/wjcc.v9.i11.2433

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4518)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-9) series.

Item

Count

PDF

291

WORD

142

HTML

2544

Tables (1-9)

230

Sum=3207

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

509

Download

802

Sum=1311

Apr 16, 2021 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Clin Cases. Apr 16, 2021; 9(11): 2433-2445
Published online Apr 16, 2021. doi: 10.12998/wjcc.v9.i11.2433

Table 2 Anti-diabetic medications in type 2 diabetes mellitus patients at an urban public hospital

Anti-diabetes medications	No. of T2DM subjects (%) n = 529
None	114 (21.6)
Insulin	129 (24.4)
Metformin	359 (67.9)
Sulfonylureas	145 (27.4)
DPP4 inhibitors	158 (29.9)
Thiazolidinediones	2 (0.4)
GLP1 agonists	3 (0.6)
SGLT-2 inhibitors	0 (0.0)
Meglitinides	1 (0.2)
Acarbose	2 (0.4)

T2DM: Type 2 diabetes mellitus; DPP4: Dipeptidyl peptidase-4; GLP1: Glucagon-like peptide 1; SGLT-2: Sodium-dependent glucose transporters 2.

Citation: Joseph DF, Li E, Stanley III SL, Zhu YC, Li XN, Yang J, Ottaviano LF, Bucobo JC, Buscaglia JM, Miller JD, Veluvolu R, Follen M, Grossman EB. Impact of type 2 diabetes on adenoma detection in screening colonoscopies performed in disparate populations. World J Clin Cases 2021; 9(11): 2433-2445
URL: https://www.wjgnet.com/2307-8960/full/v9/i11/2433.htm
DOI: https://dx.doi.org/10.12998/wjcc.v9.i11.2433